WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 525063
CAS#: 187523-35-9
Description: Flindokalner, also known BMS-204352, is a neuroprotectant. It is an opener of large conductance and calcium-activated (Maxi-K) K(sup +) channels. In vitro, acute BMS-204352 treatment (10 μM) restored the abnormal dendritic spine phenotype. In vivo, a single injection of BMS-204352 (2 mg/kg) rescued the hippocampal glutamate homeostasis and the behavioral phenotype. Indeed, disturbances in social recognition and interaction, non-social anxiety, and spatial memory were corrected by BMS-204352 in Fmr1 KO mice.
MedKoo Cat#: 525063
Name: Flindokalner
CAS#: 187523-35-9
Chemical Formula: C16H10ClF4NO2
Exact Mass: 359.03362
Molecular Weight: 359.7
Elemental Analysis: C, 53.43; H, 2.80; Cl, 9.86; F, 21.13; N, 3.89; O, 8.90
Synonym: Flindokalner; BMS-204352; BMS 204352; BMS204352; MaxiPost.
IUPAC/Chemical Name: (3S)-3-(5-Chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one
InChi Key: ULYONBAOIMCNEH-HNNXBMFYSA-N
InChi Code: InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1
SMILES Code: O=C1NC2=C(C=CC(C(F)(F)F)=C2)[C@@]1(C3=CC(Cl)=CC=C3OC)F
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 359.7 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
1: Young BL, Cooks RG, Madden MC, Bair M, Jia J, Aubry AF, Miller SA. Chiral purity assay for Flindokalner using tandem mass spectrometry: method development, validation, and benchmarking. J Pharm Biomed Anal. 2007 Apr 11;43(5):1602-8. Epub 2007 Jan 8. PubMed PMID: 17298872.
